Biotechnology

RVAC MEDICINES AND A*STAR TO BUILD CAPABILITIES FOR mRNA PRODUCTION IN SINGAPORE

SINGAPORE, Nov. 20, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered inSingapore, and the Agency for Science, Technology and Research (A*STAR) today announced...

2022-11-21 10:00 2276

Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory

Yesterday, the genetic laboratory Genotek started to work in Yerevan, Armenia. The main goal is to provide the people of the region with affordable and modern medical technologies and to create new varieties of agricultural plants and animals. YEREVAN, Armenia, Nov. 19, 2022 /PRNewswire/ -- The ...

2022-11-19 03:30 10938

MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea

- MEDICOX secures distribution right for ORAMED's oral insulin in South Korea after phase 3 of FDA approval - Contract scale up to 18 million dollars for developmental milestone and up to 15% royalty for sales - ORAMED says 1 in 7 Korean adults over 30 have diabetes and expects market potential ...

2022-11-18 17:11 2472

GenScript takes home Executive of the Year - Biotechnology at the SBR Management Excellence Awards 2022

Mr. Johnson Wang has propelled the GenScript APAC team to achieve numerous milestones despite external challenges. SINGAPORE, Nov. 18, 2022 /PRNewswire/ -- Global biotechnology corporation, GenScript Asia Pacific's President, Mr.Johnson Wang bagged the Executive of the Year - Biotechnology title...

2022-11-18 15:23 5152

Asa Ren and G42 Healthcare Team Up to Advance Genomic Sequencing and Bioinformatics in Indonesia

JAKARTA, Indonesia, Nov. 17, 2022 /PRNewswire/ --  Asa Ren Pte Ltd ("Asa Ren"), a leading consumer DNA data company based inIndonesia, has announced a strategic partnership with leading UAE-based Artificial Intelligence technology company, G42 Health Care AI Holding RSC LTD ("G42 Healthcare"). Th...

2022-11-17 19:49 3196

In operation the most innovative 11.74T MRI Core Magnet to be used on humans

GENOA, Italy, Nov. 17, 2022 /PRNewswire/ -- The world's first simultaneous multi-channel/multi-nuclear 11.74T MRI system is currently under development at Gachon University Gil Medical Center (GUGMC).   In the first Half of 2022 GUGMC successfully completed the Site Acceptance Test of the Magne...

2022-11-17 16:25 3166

Standigm Synthetic Research Center successfully accelerates drug discovery in its first year

Lab uniquely enables collaboration between chemical and AI researchers SEOUL, South Korea, Nov. 16, 2022 /PRNewswire/ -- Standigm , the workflow AI-driven drug discovery company, today announced the celebration of its Synthetic Research Center's first year. In the ...

2022-11-17 08:45 2659

RemeGen's Disitamab Vedotin Achieves First-Line Treatment Recommendation Status for Advanced Urothelial Cancer in Updated 2022 CSCO Guidelines

YANTAI, China, Nov. 17, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a Chinese commercial-stage biotechnology company, announced onNovember 5 that the Company's self-developed novel antibody-drug conjugate (ADC) Disitamab Vedotin (RC48) has been offi...

2022-11-17 08:00 3109

BDT Capital Partners acquires minority stake in Exyte

* Partnership will enhance Exyte's long-term strategy as the world leader in the design, engineering, and delivery of high-tech facilities * Exyte serves clients in the sophisticated markets of semiconductors, battery cells, pharmaceuticals, biotechnology, and data centers; industries offerin...

2022-11-16 21:31 4018

BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021

VANCOUVER, BC, Nov. 16, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce that interim results from its ongoing preclinical of BVX-1021, the Company's vaccine for SARS-CoV-1 ("SARS1") which is being evaluated in a...

2022-11-16 21:00 4277

Imaging Endpoints Announces the Appointment of Joy (Huan) Zhu, M.D., Ph.D., as Vice President, Medical Operations

SCOTTSDALE, Ariz., Nov. 16, 2022 /PRNewswire/ -- Imaging Endpoints (IE), the world's largest oncology-focused imaging CRO, announced today the addition of Joy (Huan) Zhu, M.D., Ph.D., to the company as Vice President, Medical Operations. Prior to joining IE, Joy spent 25 years in oncology clinica...

2022-11-16 21:00 2891

Gracell Biotechnologies Wins 2022 Fierce Life Sciences Innovation Award

FasTCAR next-day manufacturing autologous CAR-T platform recognized with prestigious biotech innovation award SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, Nov. 16, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharma...

2022-11-16 21:00 3707

MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System

MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five required PMA modules needed for FDA approval ST. LOUIS, Nov. 16, 2022 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VA...

2022-11-16 19:55 2533

YS Biopharma Received Qualified Person Declaration for Its PIKA COVID-19 Vaccine Facility Equivalent to European Union GMP

GAITHERSBURG, Maryland, Nov. 16, 2022 /PRNewswire/ -- YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics, today announced that...

2022-11-16 08:50 2486

Simcere and Idorsia enter into a licensing agreement for daridorexant in China

NANJING, China, Nov. 15, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group Ltd (2096.HK, "Simcere"), an innovation and R&D-driven pharmaceutical company,and Idorsia Ltd (SIX: IDIA, "Idorsia"), specialized in the discovery, development and commercialization of small molecules to transform the hori...

2022-11-16 08:32 3365

Island to present at World Antiviral Congress 2022

MELBOURNE, Australia, Nov. 15, 2022 /PRNewswire/ -- Australian mid-clinical stage antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA) is pleased to advise that CEO and Managing Director, DrDavid Foster will present at the World Antiviral Congress 2022 inSan Diego, USA which ...

2022-11-15 21:00 2254

Alphyn Biologics Completes First Cohort of Phase2a Clinical Trial of Topical Therapeutic for Mild-to-Moderate Atopic Dermatitis

ANNAPOLIS, Md., Nov. 15, 2022 /PRNewswire/ -- Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today that it has completed the first cohort of its Phase2a clinical trial of AB-101a, a topical therapeutic candidate for mild-to-m...

2022-11-15 20:30 1711

Antengene Highlights Encouraging ATG-008 Efficacy Results From TORCH-2 Study in Combination with PD-1 Antibody in Relapsed/Metastatic Cervical Cancer

* An objective response rate (ORR) of 52.4% was observed in relapsed or metastatic cervical cancer in Phase I/II TORCH-2 Study of ATG-008 (onatasertib) in combination with toripalimab, regardless of PD-L1 status * Study builds on promising results of Phase II TORCH monotherapy study in HBV+ p...

2022-11-15 16:51 2091

Nona Biosciences Announces Attendance at PEGS Europe 2022

CAMBRIDGE, Mass., Nov. 15, 2022 /PRNewswire/ -- Nona Biosciences (a wholly-owned subsidiary of HBM Holdings, HKEX: 02142) announced that the Company is attending the 14th Protein and Antibody Engineering Summit (PEGS) in Barcelona, Spain, November 14-16, 2022. The booth is located at #54. Frank ...

2022-11-15 15:57 2199

Striving Together, Upgrading the Biopharma Industry - International Biopharma Industry Week Shanghai 2022 Kicks Off

SHANGHAI, Nov. 15, 2022 /PRNewswire/ -- On November 14, the opening ceremony of the second "International Biopharma Industry Week Shanghai" (hereinafter referred to as the "IBIWS 2022") took place in the Shanghai Zhangjiang Science Hall. Themed on "Striving Together, Upgrading the Biopharma Indus...

2022-11-15 14:17 2445
1 ... 140141142143144145146 ... 307